Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
enVVeno Medical Corp shareholders approved Election of Class I directors Mr. Robert A. Berman and Mr. Matthew M. Jenusaitis at the 2022-11-30 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-11-30
Exact text from the filing
Proposal No. 1 – Election of Class I directors Mr. Robert A. Berman and Mr. Matthew M. Jenusaitis were elected as a Class II directors to serve for a three-year term that expires at the 2025 annual meeting of stockholders or until their successors are elected and qualified or until their earlier death, incapacity, removal or resignation. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Votes Mr. Robert A. Berman 2,378,488 697,978 2,373,744 Mr. Matthew M. Jenusaitis 1,869,004 1,207,462 2,373,744
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
enVVeno Medical Corp shareholders approved Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 at the 2022-11-30 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-11-30
Exact text from the filing
Proposal No. 2 – Ratification of the appointment of independent registered public accounting firm The appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was ratified. The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 5,445,167 4,108 935 0
View on SEC.gov